BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 18698838)

  • 1. Distinguishing between bioactive and modeled compound conformations through mining of emerging chemical patterns.
    Auer J; Bajorath J
    J Chem Inf Model; 2008 Sep; 48(9):1747-53. PubMed ID: 18698838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 19-nor-10-azasteroids, a new class of steroid 5 alpha-reductase inhibitors. 2. X-ray structure, molecular modeling, conformational analysis of 19-nor-10-azasteroids and comparison with 4-azasteroids and 6-azasteroids.
    Guarna A; Occhiato EG; Machetti F; Marrucci A; Danza G; Serio M; Paoli P
    J Med Chem; 1997 Oct; 40(21):3466-77. PubMed ID: 9341922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular similarity analysis uncovers heterogeneous structure-activity relationships and variable activity landscapes.
    Peltason L; Bajorath J
    Chem Biol; 2007 May; 14(5):489-97. PubMed ID: 17524980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioactive conformational biasing: a new method for focusing conformational ensembles on bioactive-like conformers.
    Musafia B; Senderowitz H
    J Chem Inf Model; 2009 Nov; 49(11):2469-80. PubMed ID: 19824683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis of compound recognition by adenosine deaminase.
    Kinoshita T; Nakanishi I; Terasaka T; Kuno M; Seki N; Warizaya M; Matsumura H; Inoue T; Takano K; Adachi H; Mori Y; Fujii T
    Biochemistry; 2005 Aug; 44(31):10562-9. PubMed ID: 16060665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targacept active conformation search: a new method for predicting the conformation of a ligand bound to its protein target.
    Klucik J; Xiao YD; Hammond PS; Harris R; Schmitt JD
    J Med Chem; 2004 Dec; 47(27):6831-9. PubMed ID: 15615532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural interaction fingerprints: a new approach to organizing, mining, analyzing, and designing protein-small molecule complexes.
    Singh J; Deng Z; Narale G; Chuaqui C
    Chem Biol Drug Des; 2006 Jan; 67(1):5-12. PubMed ID: 16492144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel method for the evaluation of 3D conformation generators.
    Takagi T; Amano M; Tomimoto M
    J Chem Inf Model; 2009 Jun; 49(6):1377-88. PubMed ID: 19435329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Torsion angle preference and energetics of small-molecule ligands bound to proteins.
    Hao MH; Haq O; Muegge I
    J Chem Inf Model; 2007; 47(6):2242-52. PubMed ID: 17880058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of protein-bound ligand conformations with respect to catalyst's conformational space subsampling algorithms.
    Kirchmair J; Laggner C; Wolber G; Langer T
    J Chem Inf Model; 2005; 45(2):422-30. PubMed ID: 15807508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycosidase inhibition: an assessment of the binding of 18 putative transition-state mimics.
    Gloster TM; Meloncelli P; Stick RV; Zechel D; Vasella A; Davies GJ
    J Am Chem Soc; 2007 Feb; 129(8):2345-54. PubMed ID: 17279749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parameterization and conformational sampling effects in pharmacophore multiplet searching.
    Fox PC; Wolohan PR; Abrahamian E; Clark RD
    J Chem Inf Model; 2008 Dec; 48(12):2326-34. PubMed ID: 19053520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Geometric accuracy of three-dimensional molecular overlays.
    Chen Q; Higgs RE; Vieth M
    J Chem Inf Model; 2006; 46(5):1996-2002. PubMed ID: 16995730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Searching for new allosteric sites in enzymes.
    Hardy JA; Wells JA
    Curr Opin Struct Biol; 2004 Dec; 14(6):706-15. PubMed ID: 15582395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Docking and scoring with alternative side-chain conformations.
    Hartmann C; Antes I; Lengauer T
    Proteins; 2009 Feb; 74(3):712-26. PubMed ID: 18704939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural interpretation of activity cliffs revealed by systematic analysis of structure-activity relationships in analog series.
    Sisay MT; Peltason L; Bajorath J
    J Chem Inf Model; 2009 Oct; 49(10):2179-89. PubMed ID: 19761254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward accurate relative energy predictions of the bioactive conformation of drugs.
    Butler KT; Luque FJ; Barril X
    J Comput Chem; 2009 Mar; 30(4):601-10. PubMed ID: 18711721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-based CoMFA as a predictive model - CYP2C9 inhibitors as a test case.
    Yasuo K; Yamaotsu N; Gouda H; Tsujishita H; Hirono S
    J Chem Inf Model; 2009 Apr; 49(4):853-64. PubMed ID: 19391630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic computational analysis of structure-activity relationships: concepts, challenges and recent advances.
    Peltason L; Bajorath J
    Future Med Chem; 2009 Jun; 1(3):451-66. PubMed ID: 21426126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ConfGen: a conformational search method for efficient generation of bioactive conformers.
    Watts KS; Dalal P; Murphy RB; Sherman W; Friesner RA; Shelley JC
    J Chem Inf Model; 2010 Apr; 50(4):534-46. PubMed ID: 20373803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.